Article Details

Endevica Bio Doses First Patient in Phase 1 Clinical Trial of TCMCB07 for the ... - Yahoo Finance

Retrieved on: 2022-07-13 18:53:21

Tags for this article:

Click the tags to see associated articles and topics

Endevica Bio Doses First Patient in Phase 1 Clinical Trial of TCMCB07 for the ... - Yahoo Finance. View article details on hiswai:

Excerpt

NORTHBROOK, Ill., July 13, 2022--Endevica Bio, a company developing first-in-class peptide drug candidates with better safety and efficacy ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up